Delivery Order SPE2DB22D1106-SPE2DB25FFAE0
- Not listed
- The Defense Logistics Agency awarded a $7,691.02 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,395.43 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, an oral diabetes medication. The contract was competitively awarded on July 21, 2025, with a completion date of July 22, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued...
- The Defense Logistics Agency awarded a $13,119.26 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a pharmaceutical product used in diabetes management. This contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,669.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication, with an ultimate completion date of July 25, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $23,840.89 to AmerisourceBergen Drug Corp for 90-day supplies of Jardiance 10 mg tablets, a common diabetes medication. This competitively awarded, firm fixed price delivery order was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed...
- The Defense Logistics Agency awarded a $13,432.45 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. The contract, executed on July 23, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed pricing under a non-competitive set-aside delivery order structure. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order functions as a...
- The Defense Logistics Agency awarded a delivery order valued at $7,460.56 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract, awarded on July 22, 2025, with completion targeted for July 23, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a $11,472.94 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform the delivery from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $7,563.77 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 10 mg tablets (90-count package). This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAE0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,797.43 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes management medication. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract received no set-aside designation, indicating it was competed among eligible contractors in an open procurement process. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999 million and extends through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The arrangement supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through a flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 7/28/25 |